Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GP

WKN: A0Q8LD | ISIN: BMG210A71016 | Ticker: MX6A
Tradegate
20.11.26 | 07:37
0,500 Euro
+8,23 % +0,038
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
GRAND PHARMACEUTICAL GROUP LTD Chart 1 Jahr
5-Tage-Chart
GRAND PHARMACEUTICAL GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,4400,49213:04
0,4460,47820.11.

Aktuelle News zur GRAND PHARMACEUTICAL GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrGRAND PHARMA Self-Developed RSV Nebulized Inhalation Drug Approved for Phase I Clinical Trial1
DoGRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE GROUP'S GLOBAL INNOVATIVE NEBULIZED INHALATION AGENT GPN01564 FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL ...-
MoGRAND PHARMA Six Products Included in 2026 National Medical Insurance Drug Catalogues and Other Lists1
10.11.GRAND PHARMA: Chinese Medicine Innovative Drug for Preventive Migraine Treatment Completes First Patient Enrollment in Phase II Clinical Trial1
10.11.GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE PHASE II CLINICAL TRIAL CONDUCTED IN CHINA OF THE GROUP'S CLASS 1 INNOVATIVE TRADITIONAL CHINESE MEDICINE ...-
GRAND PHARMACEUTICAL GROUP Aktie jetzt für 0€ handeln
05.11.GRAND PHARMA (00512): NOTICE OF AVAILABILITY TO REGISTERED SHAREHOLDERS AND REPLY FORM1
05.11.GRAND PHARMA (00512): PROXY FORM FOR THE SPECIAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 25 NOVEMBER 2026 OR ANY ADJOURNMENT THEREOF2
05.11.GRAND PHARMA (00512): NOTICE OF AVAILABILITY TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM2
05.11.GRAND PHARMA (00512): NOTICE OF THE SPECIAL GENERAL MEETING1
05.11.GRAND PHARMA (00512): (1) PROPOSED CHANGE OF AUDITORS; AND (2) NOTICE OF SPECIAL GENERAL MEETING2
05.11.GRAND PHARMA Ophthalmic Drug CBT-001 Phase III Clinical Trial Meets Primary Endpoint3
05.11.GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE INTERNATIONAL MULTI-CENTER PHASE III CLINICAL TRIAL FOR THE TREATMENT OF PTERYGIUM OF THE GROUP'S GLOBAL ...3
03.11.GRAND PHARMA (00512): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED CHANGE OF AUDITORS1
22.10.GRAND PHARMA (00512): PROPOSED CHANGE OF AUDITORS-
24.09.GRAND PHARMA (00512): INTERIM REPORT 20264
24.09.GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT1
24.09.GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT2
26.08.GRAND PHARMA (00512): 2026 INTERIM RESULTS ANNOUNCEMENT8
10.08.GRAND PHARMA (00512): DATE OF BOARD MEETING6
23.07.GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE FIRST PATIENT IS ENROLLED AND DOSED IN THE PHASE III CLINICAL TRIAL OF THE GROUP'S CLASS 1.1 INNOVATIVE ...-
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1